The pathway has been also investigated “in vivo” in Ectodermal Dysplasia (ED, OMIM 129810) patients, characterized by autosomal dominant mutation in p63 genes [18, 19]. The gene discussed is TP63; the disease is ectodermal dysplasia syndrome.